Your browser doesn't support javascript.
loading
The influence of OATP2B1 and atorvastatin on coproporphyrin isomers in rats.
Kinzi, Jonny; Grube, Markus; Hussner, Janine; Seibert, Isabell; Hamburger, Matthias; Meyer Zu Schwabedissen, Henriette E.
Afiliação
  • Kinzi J; Biopharmacy, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland.
  • Grube M; Center of Drug Absorption and Transport, Institute for Pharmacology, University Medicine Greifswald, Felix-Hausdorff-Str. 3, 17487 Greifswald, Germany.
  • Hussner J; Biopharmacy, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland.
  • Seibert I; Biopharmacy, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland.
  • Hamburger M; Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland.
  • Meyer Zu Schwabedissen HE; Biopharmacy, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland. Electronic address: h.meyerzuschwabedissen@unibas.ch.
J Pharmacol Sci ; 153(3): 170-174, 2023 Nov.
Article em En | MEDLINE | ID: mdl-37770158
ABSTRACT
Coproporphyrin I (CPI) and III (CPIII) are discussed as biomarkers for organic anion transporting polypeptides (OATPs). We report on CPI and CPIII levels in wildtype, rSlco2b1-knockout, and SLCO2B1-humanized rats at baseline and after administration of atorvastatin, an inhibitor of the CPIII-specific rOATP2B1/hOATP2B1 and the CPI/CPIII-transporting rOATP1B2. OATP-inhibition by atorvastatin leads to significantly increased CPI and CPIII serum levels. However, basal CP serum levels in rSlco2b1-knockout animals were significantly lower (CPI), or unaffected (CPIII). In the presence of atorvastatin, this genotype effect was abolished. In conclusion, our results indicate an unexpected impact of OATP2B1 on CP serum levels in rats.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Pharmacol Sci Assunto da revista: FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suíça País de publicação: JAPAN / JAPON / JAPÃO / JP

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Pharmacol Sci Assunto da revista: FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suíça País de publicação: JAPAN / JAPON / JAPÃO / JP